XORTX Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for XORTX Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for XORTX Therapeutics.

Recommendation Trends

Rating	Nov '23	Dec '23
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $9 → $14	Strong Buy	Maintains	$9 → $14	+1,184.40%	Jan 4, 2024
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $99	Strong Buy	Initiates	$99	+8,982.57%	Dec 9, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.55

from -1.15

EPS Next Year

n/a

from -1.55

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Jan 1, 2022	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	-
Revenue Growth	-	-	-	-	-	-
EPS	-1.73	-1.44	-5.22	-1.09	-1.15	-1.55
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2025
High	-
Avg	-
Low	-

EPS Forecast

EPS	2025
High	-1.00
Avg	-1.55
Low	-2.08

EPS Growth

EPS Growth	2025
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.